We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IDEX Gears Up to Report Q3 Earnings: What's in the Cards?
Read MoreHide Full Article
Key Takeaways
IDEX expects Q3 2026 adjusted EPS to rise 9.9% and revenues to grow 4.6%.
Health & Science Technologies revenues are projected to grow 11% on strong end-market demand.
Acquisitions and water demand may aid growth, while dispensing weakness and rising costs pose risks.
IDEX Corporation (IEX - Free Report) is scheduled to release third-quarter 2026 results on Oct. 28, before market open.
The Zacks Consensus Estimate for third-quarter earnings has remained steady in the past 60 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 7.7%.
The consensus estimate for revenues is pegged at $919.4 million, indicating an increase of 4.6% from the prior-year quarter’s figure. The consensus estimate for adjusted earnings is pinned at $2.23 per share, indicating an increase of 9.9% from the year-ago quarter’s number.
Let's see how things have shaped up for IDEX this earnings season.
Factors to Note Ahead of IDEX’s Results
The Health & Science Technologies (HST) segment is expected to have benefited from strength in the data center, semiconductor, space and defense markets in the third quarter. The consensus estimate for the HST segment’s revenues is pegged at $423 million, indicating an increase of 11% year over year.
An increase in demand for products across the municipal water end market is expected to have aided the Fluid & Metering Technologies (FMT) segment. Higher demand for mining application solutions business is likely to have been a tailwind as well. The consensus estimate for the FMT segment’s revenues is pegged at $321 million, indicating growth of 1.3% year over year.
IDEX has remained focused on expanding its product offerings and market presence through buyouts, which is expected to have boosted its top line. In July 2025, the company acquired Micro-LAM, Inc. (Micro-LAM), which expanded IDEX’s optics technology offerings. Also, the acquisition of Mott Corp. and its subsidiaries (Mott) in September 2024 expanded the company’s expertise in applied materials science technology capabilities across high-value end markets.
However, the Fire & Safety/Diversified Products (FSDP) segment is expected to have put up a weak show due to softness in the dispensing business arising from the unfavorable timing of dispensing projects in emerging markets. However, positive pricing is expected to have provided some relief. The consensus estimate for the segment’s revenues is pegged at $182 million, matching the year-ago quarter figure.
The escalating costs and operating expenses, due to increasing employee-related costs and professional services spending, are likely to have weighed on IEX’s bottom line in the to-be-reported quarter.
Our proven model does not conclusively predict an earnings beat for IEX this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: IEX has an Earnings ESP of 0.00% as both the Zacks Consensus Estimate and the Most Accurate Estimate are pegged at $2.10 per share. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: IEX presently carries a Zacks Rank of 3.
Here are some companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
Stanley Black & Decker, Inc. (SWK - Free Report) has an Earnings ESP of +1.10% and a Zacks Rank of 2 at present. The company is slated to release third-quarter 2026 results on Nov. 4.
Stanley Black’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 23.3%.
Deere & Company (DE - Free Report) has an Earnings ESP of +1.86% and a Zacks Rank of 3 at present. The company is slated to release third-quarter 2026 results on Nov. 25.
Deere & Company’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark in one, the average surprise being 11.1%.
Crane Company (CR - Free Report) has an Earnings ESP of +0.86% and a Zacks Rank of 3 at present. The company is scheduled to release third-quarter 2026 results on Oct. 27.
Crane’s earnings surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 10.4%.
View the Zacks #1 Rank List
Image: Bigstock
IDEX Gears Up to Report Q3 Earnings: What's in the Cards?
Key Takeaways
IDEX Corporation (IEX - Free Report) is scheduled to release third-quarter 2026 results on Oct. 28, before market open.
The Zacks Consensus Estimate for third-quarter earnings has remained steady in the past 60 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 7.7%.
The consensus estimate for revenues is pegged at $919.4 million, indicating an increase of 4.6% from the prior-year quarter’s figure. The consensus estimate for adjusted earnings is pinned at $2.23 per share, indicating an increase of 9.9% from the year-ago quarter’s number.
Let's see how things have shaped up for IDEX this earnings season.
Factors to Note Ahead of IDEX’s Results
The Health & Science Technologies (HST) segment is expected to have benefited from strength in the data center, semiconductor, space and defense markets in the third quarter. The consensus estimate for the HST segment’s revenues is pegged at $423 million, indicating an increase of 11% year over year.
An increase in demand for products across the municipal water end market is expected to have aided the Fluid & Metering Technologies (FMT) segment. Higher demand for mining application solutions business is likely to have been a tailwind as well. The consensus estimate for the FMT segment’s revenues is pegged at $321 million, indicating growth of 1.3% year over year.
IDEX has remained focused on expanding its product offerings and market presence through buyouts, which is expected to have boosted its top line. In July 2025, the company acquired Micro-LAM, Inc. (Micro-LAM), which expanded IDEX’s optics technology offerings. Also, the acquisition of Mott Corp. and its subsidiaries (Mott) in September 2024 expanded the company’s expertise in applied materials science technology capabilities across high-value end markets.
However, the Fire & Safety/Diversified Products (FSDP) segment is expected to have put up a weak show due to softness in the dispensing business arising from the unfavorable timing of dispensing projects in emerging markets. However, positive pricing is expected to have provided some relief. The consensus estimate for the segment’s revenues is pegged at $182 million, matching the year-ago quarter figure.
The escalating costs and operating expenses, due to increasing employee-related costs and professional services spending, are likely to have weighed on IEX’s bottom line in the to-be-reported quarter.
IDEX Corporation Price and EPS Surprise
IDEX Corporation price-eps-surprise | IDEX Corporation Quote
Earnings Whisper
Our proven model does not conclusively predict an earnings beat for IEX this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: IEX has an Earnings ESP of 0.00% as both the Zacks Consensus Estimate and the Most Accurate Estimate are pegged at $2.10 per share. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: IEX presently carries a Zacks Rank of 3.
You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to Consider
Here are some companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
Stanley Black & Decker, Inc. (SWK - Free Report) has an Earnings ESP of +1.10% and a Zacks Rank of 2 at present. The company is slated to release third-quarter 2026 results on Nov. 4.
Stanley Black’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 23.3%.
Deere & Company (DE - Free Report) has an Earnings ESP of +1.86% and a Zacks Rank of 3 at present. The company is slated to release third-quarter 2026 results on Nov. 25.
Deere & Company’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark in one, the average surprise being 11.1%.
Crane Company (CR - Free Report) has an Earnings ESP of +0.86% and a Zacks Rank of 3 at present. The company is scheduled to release third-quarter 2026 results on Oct. 27.
Crane’s earnings surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 10.4%.